Gilead stock pops 16% after report says coronavirus drug trial of Remdesivir is going well  @CNBC #Gilead #medicines #pharma #coronavirus #COID19 #stocks #Remdesivir #medical #vaccines #drugs  https://t.co/dPEwLb5UGj